Evidence map›Paper›PMID 27941680›Full record

ArticleMolecules (Basel, Switzerland)2016

Design, Synthesis, and Biological Evaluation of Novel Benzofuran Derivatives Bearing N-Aryl Piperazine Moiety.

Yulu Ma, Xi Zheng, Hui Gao, Chunping Wan, Gaoxiong Rao, Zewei Mao

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Ethyl Acetate Extract ofEvidence-based complementary and alternative medicine : eCAM · 2019
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yulu MaKey Laboratory of Medicinal Chemistry for Natural Resource Education Ministry, School of Chemical Science and Technology, Yunnan University, Kunming 650091, China. 22014000171@mail.ynu.edu.cn.
Xi ZhengCentral Laboratory, The No. 1 Affiliated Hospital of Yunnan University of Traditional Chinese Medicine, Kunming 650021, China. zhengxi138@163.com.
Hui GaoSchool of Traditional Chinese Medicine, Yunnan University of Traditional Chinese Medicine, Kunming 650500, China. gaohui_em@126.com.
Chunping WanCentral Laboratory, The No. 1 Affiliated Hospital of Yunnan University of Traditional Chinese Medicine, Kunming 650021, China. wanchunping1012@163.com.
Gaoxiong RaoSchool of Traditional Chinese Medicine, Yunnan University of Traditional Chinese Medicine, Kunming 650500, China. Rao_gx@163.com.
Zewei MaoSchool of Traditional Chinese Medicine, Yunnan University of Traditional Chinese Medicine, Kunming 650500, China. maozw@ynutcm.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A series of novel hybrid compounds between benzofuran and

Indexed as

Antineoplastic AgentsBenzofuransPiperazinesAnimalsAnti-Inflammatory AgentsCell Line, TumorDrug Screening Assays, AntitumorHumansLung NeoplasmsMiceNitric OxideStomach NeoplasmsAnti-Inflammatory AgentsAntineoplastic AgentsBenzofuransNitric OxidePiperazinesanticancer activityanti-inflammatory activitybenzofuranN-aryl piperazine moiety

Identifiers

PMID27941680
PMCPMC6274084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.